Lincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication with respect to unaudited financial results of the company for the quarter and half year ended on 30.09.2025.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals Limited has submitted to the exchange a copy of the newspaper publication carrying its unaudited financial results for the quarter and half year ended 30 September 2025. This is a standard regulatory compliance requirement under SEBI/LODR rules, where listed companies must publish their quarterly results in at least one English and one regional language newspaper. The actual financial numbers and detailed results would have been disclosed earlier through a separate financial results filing; this announcement simply confirms that the public notice has been duly published.
No direct impact on shareholders or stock price as this is a procedural compliance filing confirming that Q2/H1 FY26 results have been published in newspapers. Investors should refer to the original financial results announcement for actual revenue, profit, and growth figures to assess company performance.